ADVISORY, April 01, 2016 --
What:
CYBERDYNE Inc. (OTC: CYBQY – Nasdaq International Designation) (TYO:7779), a Japanese robotics and technology company, will visit the Nasdaq MarketSite in Times Square.
In honor of the occasion, Yoshiyuki Sankai, President and Chief Executive Officer, will ring the Closing Bell.
Where:
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
When:
Friday, April 1, 2016 – 3:45 p.m. to 4:00 p.m. ET
CYBERDYNE Media Contact:
Tetsu Sugie
[email protected]
Nasdaq MarketSite:
Emily Pan
(646) 441-5120
[email protected]
Feed Information:
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0
DVBS QPSK
Social Media:
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at:
http://www.facebook.com/NASDAQ.
For photos from ceremonies and events visit our Instagram Page:
http://instagram.com/nasdaq
For livestream of ceremonies and events visit our YouTube Page:
http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter page at:
http://twitter.com/nasdaq
For exciting viral content and ceremony photos visit our Tumblr Page:
http://nasdaq.tumblr.com/
Webcast:
A LiveStream of the Nasdaq Closing Bell will be available at:
https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos:
To obtain a hi-resolution photograph of the Market Close, please go to http://business.nasdaq.com/discover/market-bell-ceremonies and click on the market close of your choice.
About CYBERDYNE
CYBERDYNE, Inc. is a Japanese innovative robotics and technology company that provides products and services in the fields of medicine, care support, and labor support. CYBERDYNE, Inc. was founded in 2004 by Tsukuba University’s Professor, Dr. Yoshiyuki Sankai, who established the new academic field of Cybernics (a fusion of humans, machines and information systems). Under the philosophy that “technology is worthwhile only when used for the sake of humans and society”, the company promotes a positive cycle of innovation from the research and development to their implementation in society. The Company's world’s first cyborg-type robot, Hybrid Assistive Limb (HAL®) for medical use is used for the improvement of physical function for various patients with cerebral, nervous and muscular disorders including spinal cord injury and cerebral embolism, and the therapy for specific patients is now covered by public worker’s insurance in Germany and by public health insurance in Japan. The company has also several types of HAL® such as living support (Single joint type), care support (Lumbar type) and labor support (Lumbar type) and other products such as the cleaning robot and transportation robot. Please visit www.cyberdyne.jp/english/ for more information on CYBERDYNE, Inc.
Nasdaq International is a designation. The companies are not listed or traded on The Nasdaq Stock Market LLC, and are not subject to the same listing or qualification standards applicable to securities listed or traded on an exchange. The U.S. shares will continue to trade on the OTC.
About Nasdaq
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of approximately $9.6 trillion and nearly 10,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.
-NDAQA-


Italy Fines Apple €98.6 Million Over App Store Dominance
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 



